Furthermore, MAOA inhibitory activities of G10, G11, and G12 and molecular docking analysis were consistent with the cell viability results, suggesting that the enhanced antitumor activity of these conjugates may be attributed to the preferential accumulation in cancer cells mediated by OATPs and the increased MAOA inhibitory activity derived from INH N-acylation. The gene discussed is MAOA; the disease is cancer.